| ATC group A: Alimentary tract and metabolism |
|---|
| | A01 | Stomatological preparations | | | A02 | Drugs for acid related disorders | | | A03 | Drugs for functional gastrointestinal disorders | | | A04 | Antiemetics and antinauseants | | | A05 | Bile and liver therapy | | | A06 | Laxatives | | | A07 | Antidiarrheals, intestinal anti-inflammatory/anti-infective agents | | | A08 | Antiobesity preparations, excluding diet products | | | A09 | Digestives, including enzymes | | | A10 | Drugs used in diabetes | | | A11 | Vitamins | | | A12 | Mineral supplements | | | A13 | Tonics | | | A14 | Anabolic agents for systemic use | | | A15 | Appetite stimulants | | | A16 | Other alimentary tract and metabolism products |
|
ATC code A02 is a second-level (therapeutic) group in the WHO Anatomical Therapeutic Chemical classification. It corresponds to antacids and drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD).[1]
A02A Antacids
A02AA Magnesium compounds
- A02AA01 Magnesium carbonate
- A02AA02 Magnesium oxide
- A02AA03 Magnesium peroxide
- A02AA04 Magnesium hydroxide
- A02AA05 Magnesium silicate
- A02AA10 Combinations
A02AB Aluminium compounds
- A02AB01 Aluminium hydroxide
- A02AB02 Algeldrate
- A02AB03 Aluminium phosphate
- A02AB04 Dihydroxialumini sodium carbonate
- A02AB05 Aluminium acetoacetate
- A02AB06 Aloglutamol
- A02AB07 Aluminium glycinate
- A02AB10 Combinations
A02AC Calcium compounds
- A02AC01 Calcium carbonate
- A02AC02 Calcium silicate
- A02AC10 Combinations
A02AD Combinations and complexes of aluminium, calcium and magnesium compounds
- A02AD01 Ordinary salt combinations
- A02AD02 Magaldrate
- A02AD03 Almagate
- A02AD04 Hydrotalcite
- A02AD05 Almasilate
A02AF Antacids with antiflatulents
- A02AF01 Magaldrate and antiflatulents
- A02AF02 Ordinary salt combinations and antiflatulents
A02AG Antacids with antispasmodics
A02AH Antacids with sodium bicarbonate
A02AX Antacids, other combinations
A02B Drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)
A02BA H2-receptor antagonists
- See also: H2-receptor antagonist
- A02BA01 Cimetidine
- A02BA02 Ranitidine
- A02BA03 Famotidine
- A02BA04 Nizatidine
- A02BA05 Niperotidine
- A02BA06 Roxatidine
- A02BA07 Ranitidine bismuth citrate
- A02BA08 Lafutidine
- A02BA51 Cimetidine, combinations
- A02BA53 Famotidine, combinations
A02BB Prostaglandins
- See also: Prostaglandin
- A02BB01 Misoprostol
- A02BB02 Enprostil
A02BC Proton pump inhibitors
- See also: Proton pump inhibitor
- A02BC01 Omeprazole
- A02BC02 Pantoprazole
- A02BC03 Lansoprazole
- A02BC04 Rabeprazole
- A02BC05 Esomeprazole
A02BD Combinations for eradication of Helicobacter pylori
- A02BD01 Omeprazole, amoxicillin and metronidazole
- A02BD02 Lansoprazole, tetracycline and metronidazole
- A02BD03 Lansoprazole, amoxicillin and metronidazole
- A02BD04 Pantoprazole, amoxicillin and clarithromycin
- A02BD05 Omeprazole, amoxicillin and clarithromycin
- A02BD06 Esomeprazole, amoxicillin and clarithromycin
A02BX Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)
- A02BX01 Carbenoxolone
- A02BX02 Sucralfate
- A02BX03 Pirenzepine
- A02BX04 Methiosulfonium chloride
- A02BX05 Bismuth subcitrate
- A02BX06 Proglumide
- A02BX07 Gefarnate
- A02BX08 Sulglicotide
- A02BX09 Acetoxolone
- A02BX10 Zolimidine
- A02BX11 Troxipide
- A02BX12 Bismuth subnitrate
- A02BX13 Alginic acid
- A02BX51 Carbenoxolone, combinations excluding psycholeptics
- A02BX71 Carbenoxolone, combinations with psycholeptics
- A02BX77 Gefarnate, combinations with psycholeptics
A02X Other drugs for acid related disorders
References
